Escalon Medical Depreciation & Amortization Growth & History (ESMC)
Escalon Medical's depreciation and amortization was $37,819 for fiscal 2025.
View full Escalon Medical company overviewEscalon Medical annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $37,819 | −$8,196 | −17.81% |
| 2024 | 2024-06-30 | $46,015 | $813 | +1.80% |
| 2023 | 2023-06-30 | $45,202 | −$3,230 | −6.67% |
| 2022 | 2022-06-30 | $48,432 | $3,620 | +8.08% |
| 2021 | 2021-06-30 | $44,812 | −$5,272 | −10.53% |
| 2020 | 2020-06-30 | $50,084 | −$55 | −0.11% |
| 2019 | 2019-06-30 | $50,139 | $921 | +1.87% |
| 2018 | 2018-06-30 | $49,218 | $3,304 | +7.20% |
| 2017 | 2017-06-30 | $45,914 | $21,263 | +86.26% |
| 2016 | 2016-06-30 | $24,651 | $10,349 | +72.36% |
| 2015 | 2015-06-30 | $14,302 | $1,711 | +13.59% |
| 2014 | 2014-06-30 | $12,591 | −$1,690 | −11.83% |
| 2013 | 2013-06-30 | $14,281 | −$9,204 | −39.19% |
| 2012 | 2012-06-30 | $23,485 | −$547,165 | −95.88% |
| 2011 | 2011-06-30 | $570,650 | — | — |
Escalon Medical quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $3,000 | −$5,788 | −65.86% |
| Q2 2026 | 2025-12-31 | $8,417 | −$1,435 | −14.57% |
| Q1 2026 | 2025-09-30 | $8,170 | −$2,457 | −23.12% |
| Q4 2025 | 2025-06-30 | $8,552 | — | — |
| Q3 2025 | 2025-03-31 | $8,788 | $5,205 | +145.27% |
| Q2 2025 | 2024-12-31 | $9,852 | −$2,299 | −18.92% |
| Q1 2025 | 2024-09-30 | $10,627 | −$402 | −3.64% |
| Q3 2024 | 2024-03-31 | $3,583 | −$7,976 | −69.00% |
| Q2 2024 | 2023-12-31 | $12,151 | $771 | +6.78% |
| Q1 2024 | 2023-09-30 | $11,029 | −$456 | −3.97% |
| Q3 2023 | 2023-03-31 | $11,559 | $68 | +0.59% |
| Q2 2023 | 2022-12-31 | $11,380 | −$620 | −5.17% |
| Q1 2023 | 2022-09-30 | $11,485 | −$1,965 | −14.61% |
| Q3 2022 | 2022-03-31 | $11,491 | $715 | +6.64% |
| Q2 2022 | 2021-12-31 | $12,000 | $1,149 | +10.59% |
| Q1 2022 | 2021-09-30 | $13,450 | $2,147 | +18.99% |
| Q3 2021 | 2021-03-31 | $10,776 | −$2,956 | −21.53% |
| Q2 2021 | 2020-12-31 | $10,851 | −$717 | −6.20% |
| Q1 2021 | 2020-09-30 | $11,303 | −$603 | −5.06% |
| Q3 2020 | 2020-03-31 | $13,732 | — | — |
| Q2 2020 | 2019-12-31 | $11,568 | −$173 | −1.47% |
| Q1 2020 | 2019-09-30 | $11,906 | −$1,280 | −9.71% |
| Q2 2019 | 2018-12-31 | $11,741 | $204 | +1.77% |
| Q1 2019 | 2018-09-30 | $13,186 | $1,331 | +11.23% |
| Q3 2018 | 2018-03-31 | $11,948 | $1,065 | +9.79% |
| Q2 2018 | 2017-12-31 | $11,537 | $380 | +3.41% |
| Q1 2018 | 2017-09-30 | $11,855 | −$518 | −4.19% |
| Q3 2017 | 2017-03-31 | $10,883 | $2,956 | +37.29% |
| Q2 2017 | 2016-12-31 | $11,157 | $2,912 | +35.32% |
| Q1 2017 | 2016-09-30 | $12,373 | $7,608 | +159.66% |
| Q3 2016 | 2016-03-31 | $7,927 | $4,242 | +115.12% |
| Q2 2016 | 2015-12-31 | $8,245 | $4,628 | +127.95% |
| Q1 2016 | 2015-09-30 | $4,765 | $1,551 | +48.26% |
| Q3 2015 | 2015-03-31 | $3,685 | $824 | +28.80% |
| Q2 2015 | 2014-12-31 | $3,617 | $1,870 | +107.04% |
| Q1 2015 | 2014-09-30 | $3,214 | $364 | +12.77% |
| Q3 2014 | 2014-03-31 | $2,861 | −$6,412 | −69.15% |
| Q2 2014 | 2013-12-31 | $1,747 | −$1,502 | −46.23% |
| Q1 2014 | 2013-09-30 | $2,850 | −$893 | −23.86% |
| Q3 2013 | 2013-03-31 | $9,273 | −$6,051 | −39.49% |
| Q2 2013 | 2012-12-31 | $3,249 | $3,249 | — |
| Q1 2013 | 2012-09-30 | $3,743 | $36 | +0.97% |
| Q3 2012 | 2012-03-31 | $15,324 | −$221,238 | −93.52% |
| Q2 2012 | 2011-12-31 | $0 | −$9,887 | — |
| Q1 2012 | 2011-09-30 | $3,707 | −$236,475 | −98.46% |
| Q3 2011 | 2011-03-31 | $236,562 | — | — |
| Q2 2011 | 2010-12-31 | $9,887 | — | — |
| Q1 2011 | 2010-09-30 | $240,182 | — | — |
Escalon Medical depreciation and amortization trends
Over the last five fiscal years, Escalon Medical's depreciation and amortization decreased from $50,084 to $37,819, a change of −$12,265. The latest reported quarter, Q3 2026, shows $3,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Escalon Medical source filings ↗